IF YOU HAVE MODERATE-TO-SEVERE PLAQUE PSORIASIS
There may be a clearer tomorrow
starting today with ILUMYA®

Scroll

CLEARER STARTS HERE

Most people with moderate-to-severe plaque psoriasis were clear or almost clear with just 2 doses of ILUMYA^® (at 12 weeks). That means fewer symptoms like plaques, redness, and those flakes that seem to follow you around.

See Results

Individual results may vary.

FEWER DOSES

ILUMYA^® is dosed just 4 times a year after 2 initial doses.

DISCOVER DOSING
WITH ILUMYA®

LASTING RESULTS

Studies in people with moderate-to-severe plaque psoriasis showed that ILUMYA^® continued to clear their skin over time, even after 3 years on therapy.

See Timeline

Individual results may vary.

ILUMYA® WORKS DIFFERENTLY

ILUMYA^® is a biologic medicine that helps restore order to your immune system by blocking a key molecule that makes psoriasis worse.

WATCH ILUMYA®
IN ACTION

ILUMYA^® is not for everyone. Ask your doctor if ILUMYA^® could be the treatment you’re looking for.

Support to keep you going

Enroll in ILUMYA SUPPORT Lighting the Way^® to see if you’re eligible to receive ILUMYA^® at low or no cost.

Get the benefits

FREE eBOOK: Ready, Set, PsO!

Discover helpful tips for living more comfortably with moderate-to-severe plaque psoriasis.

Ready, Set, PsO! is a collection of useful life hacks from people just like you who have found interesting ways to master their psoriasis symptoms.

You will learn:

How to manage symptoms at work
Which foods to eat to avoid flares
How to talk to friends, family, or a date
And much, much more

COMPLETE THE FORM BELOW TO GET YOUR FREE COPY!

All fields required.

By clicking the Submit button, I authorize Sun Pharmaceutical Industries, Inc., its affiliates, subsidiaries, and third-party agents to contact me by mail, email, text message, or phone call (which may be made using an automated dialing system or an artificial or pre-recorded voice) to provide information on dermatology products, programs, services, and disease-state information and/or utilize my information for market research or analytics. Sun Pharmaceutical Industries, Inc., its affiliates, subsidiaries, and third-party agents will not utilize or distribute my personal information outside the above terms of consent.

Please refer to our Privacy Policy for more information.

IMPORTANT SAFETY INFORMATION

ILUMYA^® (tildrakizumab-asmn) is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections, pills (systemic therapy), or phototherapy (treatment using ultraviolet or UV light).

What is the most important information I should know about ILUMYA?

Do not use ILUMYA if you have had a severe allergic reaction to ILUMYA or any of its ingredients.

Get emergency medical help right away if you get any of the following symptoms of a serious allergic reaction:

feel faint

trouble breathing or throat tightness

swelling of your face, eyelids, lips, mouth, tongue or throat

chest tightness

skin rash

ILUMYA is a medicine that may lower the ability of your immune system to fight infections and may increase your risk of infections. Your healthcare provider should check you for infections and tuberculosis (TB) before starting treatment with ILUMYA and may treat you for TB before you begin treatment with ILUMYA if you have a history of TB or have active TB. Your healthcare provider should watch you closely for signs and symptoms of TB during and after treatment with ILUMYA.

Tell your healthcare provider right away if you have an infection or have symptoms of an infection, including:

fever, sweats, or chills

muscle aches

weight loss

cough

warm, red, or painful skin or sores on your body different from your psoriasis

diarrhea or stomach pain

shortness of breath

burning when you urinate or urinating more often than normal

blood in your phlegm (mucus)

Before receiving ILUMYA, tell your healthcare provider about all of your medical conditions, including if you:

have any of the conditions or symptoms listed in the section “What is the most important information I should know about ILUMYA?”

have an infection that does not go away or that keeps coming back

have TB or have been in close contact with someone with TB

recently received or are scheduled to receive a vaccine (immunization). You should avoid receiving live vaccines during treatment with ILUMYA.

are pregnant or plan to become pregnant. It is not known if ILUMYA can harm your unborn baby.

are breastfeeding or plan to breastfeed. It is not known if ILUMYA passes into your breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

It is not known if ILUMYA is safe and effective in children under 18 years of age.

What are the possible side effects of ILUMYA?

ILUMYA may cause serious side effects. See “What is the most important information I should know about ILUMYA?”

The most common side effects of ILUMYA include: upper respiratory infections, injection site reactions and diarrhea. These are not all of the possible side effects of ILUMYA. Call your doctor for medical advice about side effects.

You are encouraged to report any negative side effects of ILUMYA to FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. You are also encouraged to report side effects or ADEs (adverse drug events) to our Drug Safety Department at 1-800-406-7984 or drug.safetyUSA@sunpharma.com (preferred) with as much information as available.

Please read the full Prescribing Information and Medication Guide for ILUMYA and discuss any questions with your doctor.

IF YOU HAVE MODERATE-TO-SEVERE PLAQUE PSORIASISThere may be a clearer tomorrowstarting today with ILUMYA®

CLEARER STARTS HERE

FEWER DOSES

LASTING RESULTS

ILUMYA® WORKS DIFFERENTLY

Support to keep you going

IMPORTANT SAFETY INFORMATION

IF YOU HAVE MODERATE-TO-SEVERE PLAQUE PSORIASIS
There may be a clearer tomorrow
starting today with ILUMYA®